John Holcomb's most recent trade in MiNK Therapeutics Inc was a trade of 1,128 Common Stock done at an average price of $11.1 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MiNK Therapeutics Inc | John Holcomb | Director | Grant, award, or other acquisition of securities at price $ 11.09 per share. | 01 Dec 2025 | 1,128 | 1,128 | - | 11.1 | 12,510 | Common Stock |
| SouthState Corp | John H. Holcomb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 935 | 47,738 (0%) | 0% | 0 | Common Stock | |
| SouthState Corp | John H. Holcomb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 935 | 935 | - | - | Restricted Share Units | |
| SouthState Corp | John H. Holcomb | Director | 01 Nov 2021 | 928 | 46,797 (0%) | 0% | 0 | Common Stock | ||
| SouthState Corp | John H. Holcomb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2021 | 928 | 928 | - | - | Restricted Share Units |